GGrantIndex
Sort

82,697 grants matching vaccine development

Immune memory to SARS2 in a changing landscape

$749,245
Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2025 · AI

Neutralizing and non-neutralizing antibody effector functions in HIV infected children

$749,233
Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI

New Paradigms in Gene Regulation During Influenza Virus Infections

$749,229
Curt M Horvath · Northwestern University · U01 · FY2010 · AI

Identification of human tumor-associated antigens

$749,175
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence

$749,142
Yuying Liang · University Of Minnesota · R01 · FY2019 · AI

Discovery and validation of pan-influenza antivirals

$749,135
Megan Louise Shaw · Icahn School Of Medicine At Mount Sinai · R56 · FY2018 · AI

EVASION OF HOST IMMUNE RESPONSE BY INFLUENZA VIRUS

$749,126
Mount Sinai School Of Medicine Of Nyu · P01 · FY2000 · AI

Cancer Center Support Grant (Comprehensive)

$749,121
Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2009 · CA

Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccines

$749,101
George M Shaw · University Of Pennsylvania · R01 · FY2016 · AI

Natural Immunity Against Chlamydia trachomatis

$749,091
Toni Darville · Univ Of North Carolina Chapel Hill · R01 · FY2018 · AI

Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters

$749,043
Petros C Karakousis · Johns Hopkins University · R01 · FY2022 · AI

Linking the behavior of individual host cells to their transcriptional signatures

$749,034
Lalita Ramakrishnan · University Of Washington · DP1 · FY2013 · MH

Therapy and Prophylaxis for Genital Tract Infection

$749,000
Yingru Liu · Therapyx, Inc. · R44 · FY2014 · AI

Therapy and Prophylaxis for Genital Tract Infection

$749,000
Yingru Liu · Therapyx, Inc. · R44 · FY2015 · AI

Probing the germlines of broadly neutralizing anti-HIV antibodies in knockin mice

$748,994
Dennis R. Burton · Scripps Research Institute, The · U01 · FY2010 · AI

Nanobind Hierarchical Silica Lamella for High Molecular Weight DNA Extraction

$748,990
Kelvin Liu · Circulomics, Inc. · R44 · FY2015 · GM

Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum

$748,920
Prakash Srinivasan · Johns Hopkins University · R01 · FY2024 · AI

Rhesus HHV-8 homologue in AIDS-related malignancies

$748,902
Scott W Wong · Oregon Health & Science University · R01 · FY2016 · CA

IP20-003, Data driven transmission models to optimize influenza vaccination and pandemic mitigation strategies - COVID-19 Supplement

$748,899
Jonathan L Zelner · University Of Michigan At Ann Arbor · U01 · FY2021 · IP

Serologic memory and prevention of Pneumocystis-related COPD in AIDS macaque mode

$748,854
Karen A Norris · University Of Pittsburgh At Pittsburgh · R56 · FY2011 · AI

Pathogenic Determinants of SIV Envelope Glycoproteins

$748,850
University Of Pennsylvania · R01 · FY2002 · AI

Analysis and Response for Trust Tool (ARTT): Expert-Informed Resources for Individuals and Online Communities to Address Vaccine Hesitancy and Misinformation

$748,828
Connie Moon Sehat · Hacks/Hackers · · FY2021 · TIP

Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans

$748,825
Ivan Zanoni · Boston Children'S Hospital · R01 · FY2023 · AI

Rapid Point-of-Care Assay for detecting High Risk Human Papillomavirus

$748,820
Yu Tian · Iquum, Inc. · R44 · FY2009 · CA

Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants

$748,799
Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2022 · AI